U.S. market Closed. Opens in 21 hours 3 minutes

VVOS | Vivos Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue13.80M16.02M16.89M13.07M11.39M3.79M
Cost of Revenue5.53M6.00M4.28M2.65M2.74M1.08M
Gross Profit8.27M10.02M12.60M10.41M8.66M2.71M
Operating Expenses25.57M35.05M32.08M19.12M19.23M11.05M
Selling, General & Admin24.85M34.38M31.34M18.40M18.48M10.44M
Research & Development100.00K200.00KN/AN/AN/AN/A
Other Operating Expenses621.00K669.00K733.00K717.87K751.23K610.67K
Operating Income-17.30M-25.03M-19.47M-8.71M-10.58M-8.34M
Other Expenses / Income3.71M1.19M94.00K-16.88K-177.09K-102.97K
Before Tax Income-13.58M-23.84M-20.29M-12.06M-10.75M-8.44M
Income Tax ExpensesN/A-1.19M5.00K-3.23M137.88K102.97K
Net Income-13.58M-22.66M-20.29M-8.82M-10.89M-8.54M
Interest ExpensesN/AN/A14.00K96.68K137.88K102.97K
Basic Shares Outstanding1.22M920.48K849.32K728.38K496.43K461.93K
Diluted Shares Outstanding1.22M920.48K849.32K728.38K496.43K461.93K
EBITDA-16.68M-24.36M-19.54M-11.24M-9.87M-7.73M
EBITDA Margin-120.82%-152.03%-115.73%-86.04%-86.59%-203.72%
EBIT-13.58M-23.84M-20.27M-11.96M-10.62M-8.34M
EBIT Margin-98.42%-148.81%-120.07%-91.54%-93.18%-219.82%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙